Johnson Matthey (LON:JMAT) Stock: Insider Richard Pike Buys 12 Shares

Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Richard Pike bought 12 shares of the stock in a transaction that occurred on Wednesday, November 11th. The shares were acquired at an average cost of GBX 2,433 per share, with a total value of £291.96.

Richard Pike also recently made the following trade(s):

  • On Friday, September 11th, Richard Pike bought 17,635 shares of Johnson Matthey stock. The stock was bought at an average cost of GBX 2,248 per share, with a total value of £396,434.80.

Johnson Matthey Stock Up 1.2%

JMAT stock traded up GBX 28 during trading hours on Wednesday, reaching GBX 2,428. 275,418 shares of the stock were exchanged, compared to its average volume of 1,903,049. The firm’s 50-day moving average is GBX 2,382.13 and its 200-day moving average is GBX 2,155.77. The company has a market cap of £3.01 billion, a price-to-earnings ratio of -31.84, a PEG ratio of 49,242.50 and a beta of 0.88. The company has a debt-to-equity ratio of 69.69, a current ratio of 1.56 and a quick ratio of 0.76. Johnson Matthey PLC has a 12 month low of GBX 2,192 and a 12 month high of GBX 3,245.33.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the stock. Berenberg Bank raised their price target on shares of Johnson Matthey from GBX 2,300 to GBX 2,550 and gave the stock a “buy” rating in a research note on Wednesday, October 28th. Jefferies Financial Group reissued a “buy” rating and issued a GBX 2,330 price objective on shares of Johnson Matthey in a research report on Tuesday, August 4th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of GBX 2,370.

View Our Latest Stock Analysis on Johnson Matthey

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

Recommended Stories

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.